In July 2015, bioCSL and the influenza vaccines business of Novartis joined forces to create Seqirus,
now the second largest influenza vaccine company in the world.
Reliable supplier of seasonal influenza vaccines and antiviral treatments with the potential to rapidly respond to pandemic threats
Only major manufacturer with flexibility of 2 production technologies
Significant manufacturing capacity with networks on 3 continents: North America, Europe, and Australia
Only vaccine company with strong focus on influenza
A century of experience in combating influenza
FLUCELVAX QUADRIVALENT is a vaccine that helps protect against influenza (flu). FLUCELVAX QUADRIVALENT is for people aged 4 and older. Vaccination with FLUCELVAX QUADRIVALENT may not protect all people who receive the vaccine.
You should not get FLUCELVAX QUADRIVALENT if you have had a severe allergic reaction to any of the ingredients in the vaccine